Ovitrelle should always be administered subcutaneously and under medical supervision. The administration takes place once the optimal follicle size is reached to trigger ovulation, which coincides with the middle of the menstrual cycle.
Dr. Paloma de la Fuente Vaquero
MD, PhD, MSc
Bachelor's Degree in Medicine from the Complutense University of Madrid, with a Master's Degree in Human Reproduction and a Doctorate in Medicine and Surgery from the University of Seville. Member of the Spanish Fertility Society (SEF) and the Spanish Society of Gynecology and Obstetrics (SEGO), she performs as a gynecologist specializing in assisted reproduction in the clinic IVI Sevilla.